Streamlining mesenchymal stem cell (MSC) expansion
With increasing demand for cell and gene therapies, mesenchymal stem cells (MSCs) have gained attention for their versatility and potential in regenerative medicine. However, there remain challenges in producing large quantities of high-quality MSCs. Processes can be complex, time-consuming, and labor-intensive, while also requiring strict regulatory compliance.
